IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $168,000 | -11.1% | 4,210 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $189,000 | +397.4% | 4,210 | +528.4% | 0.01% | +400.0% |
| Q4 2020 | $38,000 | +18.8% | 670 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $32,000 | -20.0% | 670 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $40,000 | +25.0% | 670 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $32,000 | +6.7% | 670 | +34.0% | 0.00% | +50.0% |
| Q4 2019 | $30,000 | 0.0% | 500 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $30,000 | -6.2% | 500 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $32,000 | -22.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $41,000 | -75.6% | 500 | -89.1% | 0.00% | +100.0% |
| Q3 2016 | $168,000 | -64.3% | 4,600 | -77.2% | 0.00% | -50.0% |
| Q2 2016 | $470,000 | -42.4% | 20,151 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $816,000 | -27.4% | 20,151 | +11.0% | 0.00% | -20.0% |
| Q4 2015 | $1,124,000 | – | 18,151 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |